[ Price : $8.95]
Gilead and Merck say they have discontinued the KEYNOTE-D46/EVOKE-03 study of Gileads Trodelvy and Mercks Keytruda as a treatment ...[ Price : $8.95]
FDA warns Indias Zydus Lifesciences Limited about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA warns Chinas Hubei Gedian Humanwell Pharmaceutical Co. about significant CGMP deviations in its production of active pharmaceu...[ Price : $8.95]
FDA documents GMP issues at a long-troubled Bloomington, IN, fill-finish facility formerly owned by Catalent and acquired by Novo...[ Price : $8.95]
Disc Medicine says it has reached agreement with FDA on a potential regulatory path forward for its investigational therapy bitope...[ Price : $8.95]
Senators Mike Lee (R-UT) and Tommy Tuberville (R-AL) introduce the Homeopathic Drug Product Safety, Quality, and Transparency Act.[ Price : $8.95]
Eli Lilly reports Phase 3 study results showing its oral GLP-1 receptor agonist Foundayo (orforglipron) outperformed Novo Nordisk'...[ Price : $8.95]
Delegates at the American Medical Association's annual meeting vote to support stronger FDA oversight of synthetic peptide product...